Neal C Goodwin

Neal Goodwin serves as Chief Scientific Officer responsible for all research and development programs. Neal recently served as Vice President, Corporate Research Development for Champions Oncology (NASDAQ: CSBR) where his responsibilities included the development of a patient-derived xenograft pharmacology portfolio for personalized oncology and translational oncology solutions. He previously served as the Director, Research and Development and the founding Program Director of JAX Cancer Services where he established a patient-derived tumor biology program in collaboration with over 20 clinical cancer centers. Dr. Goodwin is a co-founder and former Chief Scientific Officer of ProNAi Therapeutics (now Sierra Oncology; NASDAQ: SRRA) and he has served as a senior research scientist in genomic technologies at Pharmacia. Dr. Goodwin received a Ph.D. in Microbiology from The University of Montana and served a postdoctoral fellowship in functional genomics at The Jackson Laboratory with John Schimenti (now at Cornell).